Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...

Aurora Cannabis Inc. (ACB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

Aurora Cannabis’ short interest ratio sits at 5.2. This tells us that short interest on the stock is relatively high. It also ...

Aurora Cannabis (ACB) stock jumped 45% on strong earnings, driven by record medical cannabis sales. CGC, TLRY and CRON also gained as the sector rallied on Aurora’s performance and trade tariff ...

Analysts at Roth Capital issued their Q1 2026 earnings per share estimates for shares of Aurora Cannabis in a research report issued on Thursday, February 6th. Roth Capital analyst W. Kirk expects ...

Aurora Cannabis Inc (TSX:ACB) is set to release its Q3 2025 earnings on Feb 5, 2025. The consensus estimate for Q3 2025 ...

Shares of Aurora Cannabis (NASDAQ:ACB) added ~27% in the premarket on Wednesday after the Canadian marijuana producer reported better-than-expected revenue for Q3 fiscal 2025, thanks mainly to its ...

Aurora's Toronto-listed stock soared to dizzying highs at the dawn of Canada's legal recreational cannabis market in 2018. Canadian cannabis shares plunged shortly after legalization as the industry ...

While Aurora Cannabis has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question ...

Shares of Aurora Cannabis Inc. ACB rose 6.36% to $3.68 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.35% ...

Shares of Aurora Cannabis Inc. ACB rose 3.24% to $3.82 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.25% ...